News about "positron emission tomography "

Clarity Secures FDA Fast Track Designation for 64Cu-SAR-bisPSMA

Clarity Secures FDA Fast Track Designation for 64Cu-SAR-bisPSMA

Clarity Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for 64Cu-SAR-bisPSMA for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive prostate cancer lesions.

Positron Emission Tomography | 23/08/2024 | By Aishwarya


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members